HYPOTHETICALLY SPEAKING: Two of the recent mutations in the SARS-CoV-2, one in England and one in South Africa. The question is "Do England and South Africa both have GoF Research labs operating?" If they do, and I suspect that is very likely, does this not indicate the danger, even from suspicion; of the escape of an enhanced pathogen? How can this be controlled, that is the huge economic incentive to suddenly have to produce a whole new vaccine, and if you already have the sequence then time is greatly in your favor? There must be some controls be put into place. Thank you.